Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.2
Document and Entity Information - $ / shares
6 Months Ended
Aug. 12, 2019
Jun. 30, 2019
Details    
Registrant CIK   0001514946
Fiscal Year End   --12-31
Document Type   10-Q
Document Quarterly Report   true
Document Period End Date   Jun. 30, 2019
Document Transition Report   false
Entity File Number   000-54296
Entity Registrant Name   AXIM Biotechnologies, Inc.
Entity Incorporation, State or Country Code   NV
Entity Tax Identification Number   27-4029386
Entity Address, Address Line One   45 Rockefeller Plaza
Entity Address, Address Line Two   20th Floor, Suite 83
Entity Address, City or Town   New York
Entity Address, State or Province   NY
Entity Address, Postal Zip Code   10111
Entity Address, Address Description   Address of principal executive offices
City Area Code   212
Local Phone Number   332-1677
Phone Fax Number Description   Registrant’s telephone number, including area code
Entity Current Reporting Status   Yes
Entity Interactive Data Current   No
Entity Filer Category   Non-accelerated Filer
Entity Small Business   true
Entity Emerging Growth Company   false
Entity Shell Company   false
Entity Common Stock, Shares Outstanding 62,535,419  
Entity Listing, Par Value Per Share $ 0.0001  
Amendment Flag   false
Document Fiscal Year Focus   2019
Document Fiscal Period Focus   Q2